VeriMomoligopeptide-15 est-il sûr pendant la grossesse ?
No evidence found of reproductive or developmental toxicity for oligopeptide-15 in available regulatory sources. There is no harmonised CLP classification (ECHA Annex VI) or SCCS/CIR safety assessment flagging reproductive risk. Peptides of this type are generally large, enzymatically degraded and have low dermal/systemic bioavailability when used topically, supporting negligible exposure in pregnancy (sources searched: ECHA Annex VI, SCCS/CIR, PubChem, PubMed, CosIng, EWG).
Related ingredients
Frequently asked questions
- oligopeptide-15 est-il sûr pendant la grossesse ?
- No evidence found of reproductive or developmental toxicity for oligopeptide-15 in available regulatory sources. There is no harmonised CLP classification (ECHA Annex VI) or SCCS/CIR safety assessment flagging reproductive risk. Peptides of this type are generally large, enzymatically degraded and have low dermal/systemic bioavailability when used topically, supporting negligible exposure in pregnancy (sources searched: ECHA Annex VI, SCCS/CIR, PubChem, PubMed, CosIng, EWG).
- oligopeptide-15 est-il sûr pendant l'allaitement ?
- No data indicating maternal reproductive or lactation hazards or transfer into breast milk. No harmonised classification or safety assessment (ECHA Annex VI, SCCS, CIR). Topical peptides are typically poorly absorbed and rapidly metabolised, so systemic exposure sufficient for significant breast milk transfer is unlikely (sources searched: PubMed, PubChem, CosIng, EWG).
- oligopeptide-15 est-il sûr pour la peau de bébé ?
- No hazard or mechanism evidence specific to infants. However, infant skin has an immature barrier and higher surface-area-to-weight ratio; where an ingredient has any measurable dermal absorption in adults, exposure for 0–3 yr olds is typically increased. For oligopeptide-15 there are no reported reproductive/toxic findings, so hazard and mechanism are scored 0, but exposure is increased by +1 for baby skin precaution (sources searched: PubMed, PubChem, CosIng, EWG; no SCCS/CIR/ECHA harmonised concerns found).
- Comment VeriMom évalue-t-il oligopeptide-15 ?
- VeriMom évalue oligopeptide-15 à 100/100 (pas de risques connus) sur la base du statut EU CosIng, des classifications ECHA et des études PubMed.
- Quelles sont les alternatives sûres à oligopeptide-15 pendant la grossesse ?
- Consultez notre liste d'alternatives sûres à oligopeptide-15 basée sur une fonction similaire et une classification sans risques connus.
Vérifiez chaque étiquette en 2 secondes
Obtenez VeriMom gratuitement — scannez n'importe quel produit et voyez le score de sécurité grossesse instantanément.
Avis Médical
Ces informations sont fournies à titre éducatif uniquement et ne constituent pas un avis médical. Les scores de sécurité sont basés sur des données accessibles au public et peuvent ne pas refléter tous les risques. Consultez toujours votre professionnel de santé avant d'utiliser tout produit pendant la grossesse ou l'allaitement.